Comparative bioavailability study of two oral formulations of ibuprofen

Arzneimittel-Forschung/Drug Research

Volumn 48, Issue 4, 1998, Pages 392-395

  Corpetti, Gianna ^a   Rosignoli, Maria Teresa ^a   Dionisio, Paolo ^a  

^a Università Politecnica delle Marche ACRAF Gruppo Angelini   (Italy)

Author keywords

Anti inflammatories, non steroidal; CAS 15687 27 1; Ibuprofen, clinical studies, comparative bioavailability; Moment

Indexed keywords

IBUPROFEN; MOMENT 200; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; FEMALE; HUMAN; MALE; MICROENCAPSULATION; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; TABLET FORMULATION;

EID: 0031978335     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Perez Gutthann, S., Garcia Rodriguez, L. A., Raiford, D. S., Epidemiology 8, 18 (1997)
2. Aycock, D. G., Am. Pharm. NS31, 46 (1991)
3. Anonymous, In Vivo Bioequivalence Guidances/General Information, United States Pharmacopeia, XXIII, 1929-1932
4. Anonymous, CPMP Working party on efficacy of medicinal products. Note for guidance: Investigation of bioavailability and bioequivalence. III/54/89-EN FINAL December 1991
5. Marzo, A., Balant, L. P., Arzneim.-Forsch./Drug Res. 45 (I), 109 (1995)
6. Schuirmann, D. J., J. Pharmacokin. Biopharm. 15, 657 (1987)
7. Ceppi, N., Gazzaniga, A., Gianesello, V., Arzneim.-Forsch./Drug Res. 42 (I), 556 (1992)
8. Laska, E. M., Sunshine, A., Clin Pharmacol. Ther. 40, 1 (1986)